Abigail L. Jenkins
CIK: 0001947032
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AQST
Aquestive Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Jenkins Abigail L.
Jenkins Abigail L. (SEC CIK 0001947032) files insider reports with the SEC as Director of Aquestive Therapeutics, Inc. (AQST).
Signal8 holds 2 ownership filings by Jenkins Abigail L., all Form 4s, filed between Jun 12, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jenkins Abigail L.'s filings is in WARREN, NJ.
Recent filings by Jenkins Abigail L.
Other insiders filing for Aquestive Therapeutics, Inc. (AQST)
- Cochran John, Director
- Barber Daniel, President and CEO
- Daly Richard J, Director
- Korczynski Sherry, Chief Commercial Officer
- Boyd Peter E., Chief People Officer
- Jung Cassie, Chief Operating Officer